se of mobile phones as a strategy to improve compliance to medication and attendance of clinic for HIV-exposed infants

Not Applicable

• Conditions: Paediatrics; HIV/AIDS

• Registration Number: PACTR202007654729602
• Lead Sponsor: Astrazeneca MEA I Sub Saharan Africa

Brief Summary

At 6 weeks follow-up, 90.7% (n = 68) of participants receiving phone calls reported adherence to infant Nevirapine prophylaxis, compared with 72% (n = 54) of participants in the control group (p = 0.005). Participants in the intervention arm were also significantly more likely to remain in care than participants in the control group [78.7% (n = 59) vs. 58.7% (n = 44), p = 0.009 at 6 weeks and 69.3% (n = 52) vs. 37.3% (n = 28), p < 0.001 at 10 weeks].

Detailed Description

Not available

Study Timeline

• Study Start: 2018-06-06
• Results First Posted: 2020-07-16
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

18 years and older,
- had a live birth,
- owned a mobile phone on which they could receive calls,
- willing to stay in the study area for at least 3 months after delivery and
- knew that they were HIV infected.

Exclusion Criteria

- younger than 18 years of age
- no access to mobile phone

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Adherence to Nevirapine prophylaxis and retention in care

Secondary Outcome Measures

Name	Time	Method
Early infant diagnosis and infant feeding